Bolt Biotherapeutics, Inc. BOLT Q1 2025 earnings
Reported May 12, 2025 · Before market open
Revenue$1.2MBeat by $454.5K
EPS-$5.80Beat by $1.00
Revenue estimate$767.5K
EPS estimate-$6.80
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$500.0K
EPS estimate-$3.39
Versus estimates
Revenue
Diluted EPS
Ask the moment Bolt Biotherapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Bolt Biotherapeutics, Inc. report Q1 2025 earnings?
- Bolt Biotherapeutics, Inc. (BOLT) reported Q1 2025 earnings on May 12, 2025 before market open.
- What were Bolt Biotherapeutics, Inc.'s Q1 2025 revenue and EPS?
- Bolt Biotherapeutics, Inc. reported revenue of $1.2M and eps of $-5.80 for Q1 2025.
- Did Bolt Biotherapeutics, Inc. beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $767.5K by $454.5K. EPS beat the consensus estimate of $-6.80 by $1.00.
- How did Bolt Biotherapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 76.8% from $5.3M a year earlier and eps declined 1971.4% from $-0.28.
- Where can I find Bolt Biotherapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-069188) directly on SEC EDGAR. The filing index links above go to sec.gov.